Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS- FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery
Dow 18,000 beckons, but a bottom in oil prices does not
Some posters view pessimism as a contrarian indicator, while others are taking a muted approach to investing in emerging markets.
China's reform agenda for its planned economic transition will be released next month.
A closer look at China, one of the fastest-growing major economies in the world.
Some ETF investors are piling into gold while others are betting on a strengthening greenback.
Where we see opportunities internationally and a few things to watch out for.
China funds are quite risky and vary widely in their makeup.
China funds are a very diverse and volatile lot.